96 related articles for article (PubMed ID: 18288746)
1. PFO closure devices: The disconnect between technology, technique, and indications for use.
Feldman T
Catheter Cardiovasc Interv; 2008 Feb; 71(3):403-4. PubMed ID: 18288746
[No Abstract] [Full Text] [Related]
2. PFO closure in 2008: See through a glass, darkly.
Carroll JD
Catheter Cardiovasc Interv; 2008 Feb; 71(3):388-9. PubMed ID: 18288736
[No Abstract] [Full Text] [Related]
3. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
[TBL] [Abstract][Full Text] [Related]
4. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
5. Closing a door.
Butman S
Catheter Cardiovasc Interv; 2008 Feb; 71(3):396-7. PubMed ID: 18288738
[No Abstract] [Full Text] [Related]
6. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
Majunke N; Wallenborn J; Wunderlich N; Sievert H
Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
[TBL] [Abstract][Full Text] [Related]
8. Rebound increase in migraines following PFO closure.
Bhindi R; Ormerod OJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):719; author reply 720. PubMed ID: 18360874
[No Abstract] [Full Text] [Related]
9. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
[TBL] [Abstract][Full Text] [Related]
10. Fascination with PFO's.
Tobis J
Catheter Cardiovasc Interv; 2008 Feb; 71(3):417. PubMed ID: 18288749
[No Abstract] [Full Text] [Related]
11. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
[TBL] [Abstract][Full Text] [Related]
12. Patent foramen ovale closure: past, present and future.
Steinberg DH; Pichard AD; Satler LF; Slack MC; Wunderlich N; Majunke N; Sievert H
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):881-91. PubMed ID: 17867918
[TBL] [Abstract][Full Text] [Related]
13. Cardiac perforation and tamponade 3 months after transcatheter PFO closure by STARFlex device: A case report.
Motreff P; Dauphin C; Souteyrand G
Catheter Cardiovasc Interv; 2008 Feb; 71(3):412-6. PubMed ID: 18288748
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
17. Challenging closure of a patent foramen ovale via a superior approach.
Bhindi R; Wilson N; Ormerod OJ
J Invasive Cardiol; 2008 Jan; 20(1):E18. PubMed ID: 18174624
[No Abstract] [Full Text] [Related]
18. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
19. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
20. Patent foramen ovale closure and subsequent atrial fibrillation.
Tobis J
Catheter Cardiovasc Interv; 2009 Nov; 74(6):896. PubMed ID: 19902510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
